KRTL BioTech

LSE gets U.S. nod for Refinitiv deal

LSE gets U.S. nod for Refinitiv deal

The London Stock Exchange Group said on Monday it had gained approval from the U.S. Committee on Foreign Investment for its $27 billion takeover of analytics firm Refinitiv, judging there were no national security concerns with the deal.